Fig 1. Flow chart describing case selection process and observed predominant drug resistance patterns for the five anti-TB drugs, and drug resistant patterns in MDR-TB cases, Germany 2008–2017: Isoniazid/H, Rifampicin/R, Pyrazinamide/Z, Ethambutol/E, and Streptomycin/S; DST = drug susceptibility testing.